查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363531

尿道结石管理设备市场规模、份额和趋势分析报告：按治疗类型、最终用途、地区和细分市场分類的趋势，2023-2030 年

Urolithiasis Management Devices Market Size, Share & Trends Analysis Report By Treatment Type (Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10个工作天内

价格

尿道结石管理设备市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球尿道结石管理设备市场价值将达到 22.1 亿美元。

预计2023年至2030年年复合成长率为4.9%。多年来，尿道结石罹患率的惊人增加导致了治疗方案的进步。欧洲泌尿系统协会指出，尿道结石是最常见的与文明病之一，患病10%，需要係统性的治疗方法。

尿道结石是指泌尿器官系统中结石的形成，主要包括肾臟、输尿管和膀胱。尿道结石是美国、加拿大、德国等高端国家的主要医疗保健问题，大多数情况下復发率为50%。尿道结石可以透过改变生活方式、用餐管理和基本药物来控制。然而，为了取出引起剧烈疼痛的大结石，必须采用不同的治疗方法。根据结石的大小、其在体内的位置以及泌尿生殖道的解剖变化，有侵入性和非侵入性的结石清除方法。例如，小结石可以透过体外震波碎石术（体外震波碾碎）移除，大结石可以透过手术移除（体外震波碾碎或经皮肾镜取石术）。

小结石通常不需要手术干预，可以透过药物和健康用餐来治疗。然而，随着石头越来越大，需要采取不同的方法来去除它。体外震波碎石术是常见的结石清除治疗方法之一，在2015年占据了大部分市场占有率。体内碾碎是治疗方法使用内视镜发现并缩小结石尺寸的治疗方法。使用超音波或雷射技术来崩坏结石，使较小的碎片能够通过泌尿系统。由于其高无石率，体腔内碾碎可能是预测期内的首选治疗选择。

此外，经皮肾镜取石手术是一种在体外或体内碾碎无效时移除较大结石的手术方法，通常需要住院一週。

门诊手术中心越来越受欢迎，因为它们比传统医院和诊所节省时间和金钱。因此，预计该最终用途领域在预测期内将出现良好的成长率。引入新的手术技术，如内视镜和微型配件（包括导丝、手术刀和篮子），可以快速有效地从泌尿系统中排放结石，将提高微创手术的整体可接受性，而且还在不断增加。

尿道结石管理设备市场报告亮点

  • 尿道结石在全世界范围内非常普遍，占全球目标人口的 15%，復发率为 50%。男性比女性更容易罹患肾结石。
  • 体内碾碎细分市场占据主导地位，2022 年收益占有率最高，为 34.6%，预计在预测期内将以 6.8% 的最快年复合成长率增长。体内碾碎使用内视镜观察结石，并使用雷射同时将其分解成易于处理的碎片。
  • 在已开发国家，人们越来越多地采用久坐的生活方式，加上不健康食品的消费增加，导致肾结石发病率不断上升。门诊手术服务提供者的治疗需求预计将激增，特别是由于已开发国家不健康的生活方式的改变。

目录

第1章调查方法与范围

第2章执行摘要

第3章结石管理设备市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 尿道结石管理装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章结石管理装置：治疗类型估计与趋势分析

  • 尿道结石管理设备市场：重点
  • 尿道结石管理设备市场：2022 年和 2030 年趋势和市场占有率分析
  • 体外震波碾碎（ESWL）
    • 体外震波碾碎
  • 体内碎石术
    • 2018年至2030年体内碾碎市场估计与预测
  • 经皮经皮
    • 2018年至2030年经皮肾镜取石术市场估计与预测
  • 其他治疗方法
    • 2018年至2030年其他治疗方法市场估计与预测

第5章结石管理装置：最终用途估算与趋势分析

  • 尿道结石管理设备市场：重点
  • 尿道结石管理设备市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院和诊所
  • 日间手术中心 (ASC)

第6章结石管理设备市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的尿道结石管理设备市场：要点
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018 年至 2030 年 MEA 市场估计与预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Allengers
    • Boston Scientific
    • BD
    • Cook Medical
    • ConMed
    • DirexGroup
    • Dornier MedTech
    • Potent Optotronic
    • HealthTronics
    • Karl Storz
    • Lumenis
    • Olympus
    • Richard Wolf
    • Siemens Healthcare
Product Code: GVR-1-68038-152-8

Urolithiasis Management Devices Market Growth & Trends:

The global urolithiasis management devices market was valued at USD 2.21 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 4.9% from 2023 to 2030. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week's hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Urolithiasis Management Devices Market Report Highlights:

  • Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.
  • The intracorporeal lithotripsy segment dominated the market and held the largest revenue share of 34.6% in 2022 and is expected to grow at the fastest CAGR of 6.8% over the forecast period. Intracorporeal lithotripsy involves the visualization of stones using an endoscope and their simultaneous disintegration into manageable fragments using lasers.
  • The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urolithiasis Management Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urolithiasis Management Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urolithiasis Management Devices: Treatment Type Estimates & Trend Analysis

  • 4.1. Urolithiasis Management Devices Market: Key Takeaways
  • 4.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
    • 4.3.1. Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Intracorporeal Lithotripsy
    • 4.4.1. Intracorporeal lithotripsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Percutaneous Nephrolithotomy
    • 4.5.1. Percutaneous nephrolithotomy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Other Treatments
    • 4.6.1. Other treatments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urolithiasis Management Devices: End Use Estimates & Trend Analysis

  • 5.1. Urolithiasis Management Devices Market: Key Takeaways
  • 5.2. Urolithiasis Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals & Clinics
    • 5.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers (ASCs)
    • 5.4.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urolithiasis Management Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urolithiasis Management Devices Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allengers
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boston Scientific
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. BD
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Cook Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. ConMed
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. DirexGroup
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Dornier MedTech
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Potent Optotronic
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. HealthTronics
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Karl Storz
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Lumenis
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Olympus
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Richard Wolf
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 North America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 8 Canada urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 Europe urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Germany urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 15 UK urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 17 France urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 19 Italy urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 21 Spain urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 25 Norway urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 China urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 34 Japan urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 36 India urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Australia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 40 Thailand urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 42 South Korea urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Latin America urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 47 Brazil urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 49 Mexico urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 Argentina urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa urolithiasis management devices market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 South Africa urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 UAE urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait urolithiasis management devices market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait urolithiasis management devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Urolithiasis management devices: Market outlook
  • Fig. 8 Urolithiasis management devices: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Urolithiasis management devices market driver impact
  • Fig. 14 Urolithiasis management devices market restraint impact
  • Fig. 15 Urolithiasis management devices market strategic initiatives analysis
  • Fig. 16 Urolithiasis management devices market: Treatment type movement analysis
  • Fig. 17 Urolithiasis management devices market: Treatment type outlook and key takeaways
  • Fig. 18 Extracorporeal shock wave lithotripsy (ESWL) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Intracorporeal lithotripsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Percutaneous nephrolithotomy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Other treatments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urolithiasis management devices market: End use movement analysis
  • Fig. 23 Urolithiasis management devices market: End use outlook and key takeaways
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global urolithiasis management devices market: Regional movement analysis
  • Fig. 27 Global urolithiasis management devices market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)